Stock Chart

SRPT

$16.42 -4.76%
Score: 33.3 AVOID NEW MONEY
LEAPs: SELL $20
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $20
Premium: $4.00
Expiry: Jun 17, 2027
Target: $20
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 1.36x (vs SPY: 1.6x | vs QQQ: 1.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 10, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About SRPT - Sarepta Therapeutics,, Inc. Common Stock

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of …

Key Statistics

Market Cap $2B
P/E Ratio 862.00

This SRPT stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track SRPT's price movements with trendlines, gamma walls, and key support/resistance levels.